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Kevin W. Southerland, MD*, and Carmelo A. Milano, MD*,†Congestive heart failure is a devastating clinical syn-drome, which affects millions of individuals. In fact, half
of the individuals diagnosed with congestive heart failure die
within 5 years of diagnosis.1 The best treatment option for
individuals with end-stage heart failure is heart trans-
plantation; however, the effectiveness of this modality is
limited by a donor shortage. Because of the discrepancy
between the number of potential recipients and available
donors, an increasing number of patients have been bridged
to transplant with mechanical circulatory support, partic-
ularly left ventricular assist devices (LVAD).matter r 2014 Elsevier Inc. All rights reserved.
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the ﬁrst-generation pulsatile-ﬂow devices were mixed.
However, with the introduction of the smaller, more
durable, continuous-ﬂow devices, posttransplant survival
outcomes have improved and are equivalent to trans-
plantation outcomes for patients who are not supported on
an LVAD.2,3 These encouraging results, coupled with a
continued donor shortage, have led to a dramatic increase
in the use of LVADs for bridging to transplantation. In fact,
in 2011, 37% of transplant recipients were bridged with
LVADs.4
The increased use of LVADs has undoubtedly improved
patient outcomes, yet at the same time, it has created
new technical challenges for the cardiothoracic surgeon.
This article reviews the operative technique of heart
transplantation in patients with continuous-ﬂow LVADs
(Figs. 1-13).47
Figure 1 Implantation of LVAD. The future transplant procedure should be considered at the time of the LVAD implant procedure. The
important structures, which can become scarred to the posterior sternal closure, include the LVAD outﬂow graft and the right ventricle (RV).
The outﬂow graft for both axial ﬂow (A) and centrifugal pumps (B) should be positioned just lateral to the right atrium and not immediately
posterior to the sternal closure. Furthermore, the graft should be attached lower on the ascending aorta and to the right lateral aspect. The
lower positioning of the outﬂow graft on the ascending aorta leaves ample distal ascending aorta, which can be used for the subsequent aortic
anastomosis during heart transplantation.
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Figure 2 Placement of GORE-TEX patch. Many surgeons use a prosthetic membrane to cover the RV and the outﬂow graft at the time of sternal
closure after the LVAD implant. This membrane is most commonly composed of GORE-TEX and is sutured to the lateral pericardial edges.
This membrane serves to protect the right ventricle, the outﬂow graft, and other important cardiac structures. Because the membrane is
sutured laterally to the pericardial edges, it also helps the surgeon identify the pericardial edges at the time of reoperation. RV ¼ right
ventricle.
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Figure 3 Peripheral cannulation. After a period of outpatient convalescence and end-organ recovery, the LVAD patient is considered for
subsequent heart transplantation. Typically, the period of recovery between the LVAD procedure and heart transplantation is greater than
2 months. Preoperative chest CT should be obtained routinely to further deﬁne the anatomy before considering transplant. A suitable donor
heart is matched to the recipient based on size, ABO blood type compatibility, and HLA antibody compatibility. Once the procurement
operation has begun and the donor heart is visualized and determined to be suitable, the recipient LVAD removal and heart transplant
procedure can be initiated. After general anesthesia, a radial arterial line and a right internal jugular Swan-Ganz catheter are placed. The Swan-
Ganz catheter is left in the SVC during the procedure and ﬂoated into the pulmonary artery once the patient is weaned off cardiopulmonary
bypass (CPB). After the patient is positioned, and the skin prepared, peripheral cannulation for CPB is established before the reoperative
sternotomy. Although reoperative sternotomy can generally be performed without injury to vascular structures, peripheral cannulation adds
safety. Although there are many options for peripheral cannulation, we prefer cutting down the right axillary artery and application of an
8-mm Hemashield graft in an end-to-side conﬁguration to provide arterial inﬂow for CPB. Venous drainage for CPB is established
percutaneously by accessing the right common femoral vein. Intraoperative transesophageal echocardiography (TEE) is used to conﬁrm the
position of the guide wire introduced from the right femoral vein and guided into the right atrium. This site is sequentially dilated, and then a
#25 French multistage venous cannula is guided over the wire into the right atrium. Before these cannulation procedures, the patient should
be systemically administered heparin. Importantly, after initiating CPB, the LVAD pump speed should be decreased to avoid generation of
negative pressure in the LV, which could lead to air entrainment and subsequent embolization. However, the LVAD pump should not be
turned off if the outﬂow graft cannot be clamped, as regurgitant ﬂow will occur, and may lead to LV distention. CT ¼ computed tomography;
HLA ¼ human leukocyte antigen; SVC ¼ superior vena cava; LV ¼ left ventricle.
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Figure 4 Sternotomy or removal of GORE-TEX membrane. After peripheral cannulation for CPB is secured, median sternotomy is performed
with an oscillating saw. The posterior table of the sternum is sawed while providing upward traction. After the sternotomy is completed, the
GORE-TEX membrane should be visible. Dissection is conducted toward the lateral margins of the prosthetic membrane, which should lead
to the pericardial edges. Once the pericardial edges are deﬁned, dissection is conducted to free the pericardium from the underlying
epicardium or LVAD components. Typically, during reoperative cardiac surgery, the diaphragmatic pericardium is a good point of initiation
for the dissection. On LVAD cases, however, this region is usually more scarred owing to the presence of the pump and the outﬂow graft.
Therefore, the left lateral pericardium in the region of the main pulmonary artery is often a better starting point. After the pericardial edges are
dissected in all directions, the GORE-TEX membrane is removed and discarded. CPB ¼ cardiopulmonary bypass.
Heart transplantation after left ventricular assist device 51
Figure 5 Bicaval venous drainage. The bicaval heart transplant technique requires dual venous drainage for CPB. The percutaneous femoral
vein drainage cannula can be withdrawn into the IVC, and clamping above this level enables performance of the IVC anastomosis. Other
surgeons have described dividing the IVC and utilizing vacuum drainage to clear the ﬁeld without a clamp on the IVC. The SVC must also be
identiﬁed. The aorta and LVAD outﬂow graft are retracted medially; the SVC is identiﬁed and cannulated with a right angle venous drainage
cannula. The SVC is circumferentially dissected at the level of the right pulmonary artery, and an umbilical tape is placed around the SVC. The
SVC cannula is spliced into the venous drainage line. Tightening the tape around the SVC cannula and clamping the IVC at the level of the
diaphragm achieve complete bicaval venous drainage. CPB ¼ cardiopulmonary bypass; IVC ¼ inferior vena cava; SVC ¼ superior vena cava.
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Figure 6 Extirpation of LVAD. The LVAD pump is generally encased in a pocket of dense scar tissue, which must be incised. After complete
mobilization of the LVAD pump, while on cardiopulmonary bypass, the LVAD pump is turned off, and the outﬂow graft is clamped and
divided near the ascending aorta. The LVAD inﬂow cannula is then removed from the LV apex, and a LV vent is placed through the apical
hole into the LV cavity. Finally, the power cord, which usually courses through the right rectus muscle, is dissected, mobilized, and divided.
At this time, the LVAD pump is removed from the ﬁeld. Any residual power cord can be removed at the end of the procedure by dissecting
the tract beginning from the site where the cord exits the abdominal wall. This exit site and the inside of the power cord are contaminated;
therefore, this is done at the end of the procedure. The residual tract in the abdominal wall can be packed with gauze and treated with
dressing changes postoperatively. LV ¼ left ventricle.
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Figure 7 Excision of native heart. When the donor heart has been delivered to the operating room, the native heart can be excised. The aorta is
cross clamped. The SVC tape is tightened around the SVC cannula, and the IVC is clamped at the level of the diaphragm above the femoral
venous cannula. The native heart is excised at the level of the right and left atrioventricular grooves, initially leaving much of the native atria.
On the right side, the excision is conducted near the course of the right coronary artery, inferiorly toward the coronary sinus. The aorta is then
divided at the level of the sinotubular junction. Most of the native aorta is initially retained and trimmed back later. The main pulmonary
artery is divided at the level of the pulmonic valve. Next, the left ventricle is excised. On the left side, the excision is conducted through the
coronary sinus, which travels in the left atrioventricular groove. This dissection essentially retains the majority of the native left atrium, which
is trimmed back later. The native heart is then removed from the ﬁeld. SVC ¼ superior vena cava; IVC ¼ inferior vena cava.
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Figure 8 Creation of left atrial, SVC, and IVC cuff. (A) The interatrial groove is dissected to separate the left and right atrial cuffs.
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Figure 8 Continued (B) The right atrial cuff is then divided into 2 cuffs, one attached to the SVC superiorly and another to the IVC inferiorly.
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Figure 8 Continued (C) The SVC cuff is mobilized to the level of the azygos vein, taking care to avoid injury to the right pulmonary artery.
The IVC cuff is mobilized back to the diaphragm, taking care to avoid injury to the right inferior pulmonary vein. SVC ¼ superior vena cava;
IVC ¼ inferior vena cava.
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Figure 9 Preparation of donor heart and left atrial anastomosis. The future LV vent is now placed through a purse-string suture in the right
superior pulmonary vein; the vent is guided across the left atrial cuff, and the tip is temporarily positioned in the left pulmonary veins. The left
atrial cuff is trimmed, and the recipient left atrial appendage is removed. Next, the donor heart is taken out of the cold static storage and
brought up to the ﬁeld. While on ice, the interatrial septum is inspected and any patent foramen ovale is closed with a 4-0 PROLENE suture.
The pulmonary veins if still present on the left atrium are opened into a conﬂuent left atrial cuff. If the donor was used for lung grafts, the
pulmonary veins will have been removed from the left atrium and remain with the lung graft. The donor aorta and pulmonary artery are
carefully separated. All valves are inspected, and any intracardiac thrombus is removed. The ﬁrst anastomosis to be performed is the left atrial
anastomosis. The heart is held toward the assistant's side (patient's left side), and the left lateral part of the anastomosis is performed.
Typically, we use a running 3-0 PROLENE suture. After the running suture is completed to the point of the left atrium closest to the IVC,
the other limb of the suture is used to complete the anastomosis at the roof of the left atrium. Before completion of the anastomosis, the LV
vent is repositioned across the mitral valve into the left ventricle of the donor heart. LV ¼ left ventricle; RA ¼ Right atrium; MV¼mitral valve;
IVC ¼ inferior vena cava.
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Figure 10 Aortic anastomosis. After completion of the left atrial anastomosis, a solumedrol bolus (1000 mg) is administered intravenously. The
heart is then treated with cold blood cardioplegia, which is administered into the ascending aorta, which can be temporarily clamped. The
cardioplegia should be visualized emanating from the coronary sinus. After the cardioplegia is delivered, the donor and recipient aortas are
trimmed and a tension-free end-to-end aortic anastomosis is performed with running 4-0 PROLENE suture. Before completion of the aortic
anastomosis, the left heart is deaired. The operative ﬁeld is continuously ﬂooded with carbon dioxide. Next, the aortic cross clamp is removed
and the donor heart is reperfused. Following reperfusion, an additional ascending aortic vent is placed for further deairing. The LV vent is
turned on to fully decompress the left ventricle. Additionally, intraoperative TEE is used to assess for the presence of intracardiac air, which
can be removed with the LV or aortic root vents. Ao ¼ aorta; PA ¼ pulmonary artery; LV ¼ left ventricle; TEE ¼ transesophageal
echocardiography.
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Figure 11 Pulmonary artery anastomosis. After reperfusion, a drop sucker is placed through the superior vena cava into the coronary sinus to
capture the heart's venous drainage. The remaining anastomoses (pulmonary artery [PA], IVC, and SVC) can be performed with the heart
reperfused, thus reducing the duration of the ischemic period. Owing to anatomical constraints, it may be difﬁcult to complete the back wall
of the PA anastomosis after the completion of the aortic anastomosis. If this is the case, the back wall of the PA anastomosis can be performed
before the aortic anastomosis, and the anterior portion of the PA anastomosis can then be completed after reperfusion. The PA, IVC, and SVC
anastomoses are generally completed in this order with running 4-0 PROLENE sutures. Again, pump sucker clearance of the coronary sinus
efﬂuent is necessary to facilitate visualization. IVC ¼ inferior vena cava; SVC ¼ superior vena cava.
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Figure 12 IVC anastomosis. The IVC anastomosis is facilitated by positioning the patient in a head-down (Trendelenburg) position.
Additionally, stay sutures can be placed on the anterior aspect of the donor IVC retracting the acute margin of the heart cephalad enabling
visualization. The PA, IVC, and SVC cuffs must be carefully trimmed and sized to avoid redundancy, which can lead to a kink after the heart
ﬁlls. IVC ¼ inferior vena cava; PA ¼ pulmonary artery; SVC ¼ superior vena cava.
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Figure 13 SVC anastomosis. The SVC anastomosis is constructed around the drop sucker, which continues to evacuate blood from the
coronary sinus (this sucker is removed before completion of the anastomosis). After completion of all the anastomoses, the SVC tape and the
IVC clamp are removed. All anastomoses are inspected for bleeding. Atrial and ventricular epicardial pacing wires are placed. The lungs are re-
expanded, and the heart is deaired with intraoperative TEE guidance. After deairing is completed, the LV vent and ascending aortic vents are
removed. Typically, a dobutamine or low-dose epinephrine infusion is started before discontinuing CPB. Inhaled nitric oxide in the ventilator
circuit is frequently employed if there is high pulmonary vascular resistance or RV dysfunction. After CPB is terminated, the heparin is
reversed fully with protamine. Patients are typically receiving warfarin before the procedure; therefore, fresh frozen plasma and vitamin K
reversal of warfarin are warranted. Continuous-ﬂow LVAD patients frequently experience a form of acquired von Willebrand disease with
destruction of high-molecular-weight von Willebrand factor. Therefore, desamino-D-arginine vasopressin (0.3 mg/kg) and platelet
transfusions may be warranted as well. If there is RV dysfunction or coagulopathic bleeding, sternal closure may be delayed. Finally,
intraoperative TEE is used to inspect RV and LV functions, as well as to examine all valves and anastomoses. SVC ¼ superior vena cava;
IVC ¼ inferior vena cava; TEE ¼ transesophageal echocardiography; LV ¼ left ventricle; CPB ¼ cardiopulmonary bypass; RV ¼ right
ventricle.
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Heart transplantation after left ventricular assist device 63Postoperative Management
The postoperative management of heart transplant recipients
bridged with LVADs is similar to conventional heart
transplantation. Patients are transferred from the operating
room to the intensive care unit. Patients are mechanically
ventilated, and standard monitoring consists of continuous
arterial blood pressure, pulse oximetry, and electrocardio-
gram. Hemodynamics are monitored via a Swan-Ganz
catheter. Urine output, temperature, and mediastinal drain
output are also monitored.
Early complications include hemorrhage and primary
graft dysfunction, most frequently right-sided dysfunction.
Late complications consist of acute rejection, cardiac
allograft vasculopathy, infection, renal insufﬁciency, and
neoplasm.
Immunosuppression protocols may vary. However, at our
institution, high-risk patients are induced with Simulect in
addition to a solumedrol bolus. All patients are managedwith a maintenance regimen consisting of tacrolimus,
prednisone, and CellCept.References
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